THE PATHOGENESIS OF SEPTIC SHOCK

被引:34
作者
SRISKANDAN, S
COHEN, J
机构
[1] Department of Infectious Diseases and Bacteriology, Royal Postgraduate Medical School, London
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0163-4453(95)90647-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:201 / 206
页数:6
相关论文
共 37 条
[1]  
Kieft, Hoepelman, Zhou, Rozenberg-Arska, Struyvenberg, Verhoef, The sepsis syndrome in a Dutch university hospital, Arch Intern Med, 153, pp. 2241-2247, (1993)
[2]  
Marks, Marks, Luce, Et al., Plasma tumour necrosis factor in patients with septic shock, Am Rev Respir Dis, 141, pp. 94-97, (1990)
[3]  
Krausz, Cohen, Shock, Oxford Textbook of Pathology, pp. 540-551, (1992)
[4]  
de Azavedo, Animal models for toxic shock syndrome: an overview, Rv Infect Dis, 11, pp. S205-S209, (1989)
[5]  
Himanen, Pyhala, Olander, Et al., Biological activities of lipoteichoic acid and peptidoglycan-teichoic acid of Bacillus subtilis 168 (Marburg), J Gen Microbiol, 139, pp. 2659-2665, (1993)
[6]  
Kim, Watson, A purified group A streptococcal pyrogenic exotoxin, J Exp Med, 131, pp. 611-628, (1970)
[7]  
Martich, Danner, Ceska, Suffredini, Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents, J Exp Med, 173, pp. 1021-1024, (1991)
[8]  
Timmerman, Mattson, Martinez-Martinez, Et al., Induction of release of tumour necrosis factor from human monocytes by staphylococci and staphycoccal peptidoglycans, Infect Immun, 61, pp. 4167-4172, (1993)
[9]  
Lynn, Golenbock, Lipopolysaccharide antagonists, Immunol Today, 13, pp. 271-276, (1992)
[10]  
Webb, Gascoigne, T-cell activation by bacterial super-antigens, Curr Opinion Immunol, 6, pp. 467-475, (1994)